Minnesota’s medtech momentum creates new opportunity for electric cooperatives

Minnesota has become one of the most competitive destinations for life sciences and medical technology (medtech) investment in the country. According to the Hickey Institute’s 2025 Life Sciences and MedTech Site Selection Strategy Report, the Minneapolis-St. Paul region is now one of the most critical national hubs for biomanufacturing and medical device production, fueled by strong institutional partnerships, advanced R&D and a globally competitive workforce.

With more than 800 life science and healthcare companies already operating in the region, this growth is active and gaining momentum. For our member-owner cooperatives, this signals a growing need to anticipate potential rising demand for life science energy supply. It also underscores the importance of aligning energy infrastructure strategies with the specific siting needs of advanced manufacturing and biomedical research facilities.

A strategic shift in the US life science geography favors Minnesota

Site selectors are increasingly prioritizing locations with modern infrastructure, proven utility reliability and scalable energy service. While traditional markets like Boston, San Diego and the Bay Area continue to dominate in R&D headquarters functions, the next wave of investment is being driven by companies seeking reliable, cost-effective locations for testing, manufacturing and distribution.

Minnesota is meeting that demand. The Minneapolis-St. Paul region offers life science companies with the following:

• Proximity to international airports and cold-chain freight infrastructure
• Highly specialized talent from institutions like the University of Minnesota and Mayo Clinic
• Access to FDA regulatory expertise and medical device IP leadership
• A deeply integrated supply chain for precision manufacturing
• Scalable real estate for GMP, wet lab and clean room buildouts

These factors are driving life science firms to shift major operations to mid-sized metros, such as MSP, and increasing the energy demand footprint for co-ops serving surrounding areas.

Electric demand profiles in life sciences require strategic planning

Life sciences operations — particularly manufacturing, R&D and controlled-environment facilities — exhibit energy load profiles that differ from those of traditional industrial users. Key electric service considerations include:

• High HVAC and air-handling loads in clean rooms and laboratories
• Continuous energy usage for temperature- and humidity-sensitive environments
• Backup power requirements for clinical trial storage and biologics production
• Precision demand control for equipment calibration and process validation
• Potential for on-site generation or microgrid integration

For member-owner cooperatives, this means preparing not only for higher base loads, but for complex demand cycles and redundancy needs that require grid flexibility and proactive engineering.

The role of policy, investment and national recognition

Federal and state policy support further strengthens Minnesota’s position. The “Minnesota MedTech 3.0” initiative, one of only a select group of federally designated U.S. Tech Hubs, is building momentum through coordinated investment in AI, data science and innovative medical devices.

The state of Minnesota’s business climate includes incentives like the Minnesota Investment Fund and Angel Tax Credit. These tools, combined with federal grants and R&D tax credits, offer a competitive capital environment for expanding firms. For member-owner cooperatives, this is a signal that multi-year investment in load-serving infrastructure around key corridors will be matched by long-term demand.

What’s next for electric cooperatives

Minnesota’s future in life sciences is not speculative. It is already in motion. The infrastructure demands of this sector will not fit legacy assumptions or outdated load profiles. If electric cooperatives recalibrate and act now, there is significant potential to capitalize on this momentum.